Evidence map›Paper›PMID 19590685›Full record

ArticleEnvironmental health perspectives2009

Increased expression of histone proteins during estrogen-mediated cell proliferation.

Zheying Zhu, Robert J Edwards, Alan R Boobis

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Current concepts in neuroendocrine disruption.General and comparative endocrinology · 2014
    Review
  8. Article
  9. Review
  10. Review
  11. Epigenomic disruption: the effects of early developmental exposures.Birth defects research. Part A, Clinical and molecular teratology · 2010
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zheying ZhuDepartment of Experimental Medicine and Toxicology, Imperial College London, London, United Kingdom. z.zhu@imperial.ac.uk
Robert J Edwards
Alan R Boobis
Imperial College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is concern about the potential risk posed by compounds with estrogen-like activity present in the environment. As previous studies have shown that combined exposure to such compounds results in dose additivity, it should be possible to assess estrogen exposure with suitable biomarkers of effect.

objectivesOur goal was to identify candidate protein biomarkers of effect for estrogenic compounds.

methodsIn the search for biomarkers, we assessed the effect of several estrogenic compounds on the expression profile of proteins in breast-derived cell lines varying in their estrogen receptor (ER) phenotype using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. We identified responsive proteins, after separating them by SDS-polyacrylamide gel electrophoresis, and analyzing the trypsin-digested proteins by tandem mass spectrometry.

resultsThe estrogenic compounds 17beta-estradiol, genistein, bisphenol A, and endosulfan produced similar protein profile changes in MCF-7 cells (phenotype: ERalpha(+)/ERbeta(+)), but had no effect on MDA-MB-231 (ERalpha(-)/ERbeta(+)), MCF-10F (ERalpha(-)/ERbeta(+)), or MCF-10A (ERalpha(-)/ERbeta(-)) cells. The most responsive proteins in MCF-7 cells were identified as histones H2A, H2B, H3, and H4. Histone levels were not increased in cell lines that showed no proliferative response to estrogens despite their rapid intrinsic growth rate in culture.

conclusionOur results indicate that ER-mediated cell proliferation results in up-regulation of core histone proteins.

Indexed as

Benzhydryl CompoundsBisphenol A CompoundsCell LineCell ProliferationEndosulfanEstradiolEstrogen Receptor alphaEstrogen Receptor betaEstrogensGene Expression RegulationGenisteinHistonesHumansPhenolsBenzhydryl Compoundsbisphenol ABisphenol A CompoundsEndosulfanEstradiolEstrogen Receptor alphaEstrogen Receptor betaEstrogensGenisteinHistonesPhenolsbiomarkersbreast cancer cell linesestrogenic compoundshistonesprotein profilesSELDI-TOF MS

Identifiers

PMID19590685
PMCPMC2702408
OpenAlexW2124964054

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.